Innate vs Adaptive Immunity
Feature | Innate Immunity | Adaptive Immunity |
Components | Neutrophils, macrophages, monocytes, dendritic cells, NK cells, complement, epithelial barriers, enzymes Other classes of lymphocytes: • Gamma delta T cells, • NK-T cells • B-1 cells • marginal-zone B cells Cytokines → TNF-a, interleukins (IL-1, IL-6, IL-8, IL-12, IL-16, IL-18), IFN-a, ß and TGF-B | T cells, B cells, Antibodies Memory cells (B & T cells); Cytokines (IL-2, IL-4, IL-5, IFN-gamma) Complement Pathway Adapt while playing game (Gamma) → 2, 4, 5 (3 interfered) |
Mechanism | Germline encoded | V(D)J recombination during lymphocyte development |
Response to Pathogens | Nonspecific, rapid (mins–hrs), no memory | Highly specific, Slower onset, Memory response present |
Secreted Proteins | Lysozyme, complement, CRP, defensins, cytokines | Immunoglobulins, Cytokines |
Pathogen Recognition | Toll like receptors (TLRs) • recognize PAMPs (e.g., LPS, flagellin, nucleic acids) • NF-κB activation | Declines with age (immunosenescence) |

- Gamma delta T lymphocytes:
- They are a subset of T cells that have innate-like properties.
Immune Privilege
- Organs like eye, brain, testes (seminiferous tubules), placenta limit immune responses
- prevent inflammatory damage.
- Allograft rejection is less likely in these areas.
Passive vs Active Immunity
Feature | Active Immunity | Passive Immunity |
Means of Acquisition | Exposure to exogenous antigens | Receiving preformed antibodies |
Onset | Slow | Rapid |
Duration | Long-lasting (immunologic memory) | Short (half-life ≈ 3 weeks) |
Examples | - Natural infections - Vaccines - Toxoids | - IgA in breast milk - Maternal IgG via placenta - Antitoxins - Monoclonal antibodies |
Notes | - Often combined with passive (e.g., Hep B, Rabies) for better coverage | - IVIG & other globulin preps used for temporary protection - Used in urgent scenarios |
Natural Killer (NK) Cells
Arms:

- Kill via antibody-dependent cell-mediated cytotoxicity (ADCC)
→ CD16 binds Fc region of IgG
Inhibitory arm:
- Prevents killing self-cells.
- Self-Cell Recognition (ID Card):
- Self-cells have MHC1 (ID card).
- NK sees MHC1 → Inhibitory arm activated → No kill.
Activating arm:
- Activating arm, NKG2D, then kills these cells.
- Requires Interleukin IL-2, IL-12, IL-15.
- Activated by:
- Nonspecific activation signal on target
- Lack of MHC I on target surface
- Viruses/cancers destroy MHC1.
- Mnemonic: Natural killer going 2 destroy (NKG2D)
CD Markers:
- CD16, CD56, CD94.
- Mnemonic: "16in bicep 56in chest and 94 kg weight" (describes "strong bahubali natural killer cell").
T Lymphocytes
T-cell Receptors (TCR):

- 95%:
- Alpha-beta T lymphocytes.
- MHC dependent receptors for peptide antigens.
- 5%:
- Gamma delta T lymphocytes → found in GIT, GUT
- They are a subset of T cells that have innate immunity like properties.
- Mucosa of GIT = Prevent Ag entry like innate immune cells
- Possess gamma delta (γδ) T cell receptors.
- directly recognize lipid antigens
- independently of MHC presentation.
- Direct killing of infected macrophages
- Provide protection against mycobacteria
- Kills extracellular bacteria by perforin granulysin pathway
CD Markers:
- Mnemonic: "CD markers = 1→8, 28"
Pan T-cell marker & signal transducing:
- CD3 (on all T-cells)
- Mnemonic: Pantie size 3
Helper T-cell
- CD4.
- Help B cells make antibodies
- Secrete cytokines to recruit phagocytes & activate leukocytes
- ↓ → HIV
- ↑ → Sarcoidosis.
- Mnemonic: For (CD4) helping (Helper)
- More help for SARATHA (↑ ratio)
- No help for HIV people (↓ ratio)
Types

Interleukins | Helper cells | Effect |
IL 2 | Th1 | Stimulate Th1 and NK cells → vicious loop |
IL 13 | Th2 | Mucus production |
IL 4 | Th2 | Isotype switch |
IL 5 | Th2 | Eosinophil → Type 1 hypersensitivity |

Interleukin | Function | Mnemonic / Notes |
IL-1 | Causes fever (pyrogen). | ㅤ |
IL-2 | Secreted by T Cells Growth of helper, cytotoxic, regulatory T cells & NK cells | 2 → T |
IL-3 | Bone marrow stem cell growth (like GM-CSF) | 3 → B |
IL-4 | Differentiates Th → Th2 B Cell IgE class switching. | BEG (B cell, IgE, IgG switching) 4 help |
IL-5 | Promotes B Cell IgA class switching; Eosinophil, basophils, mast cells activation Type 1 hypersensitivity | “I have 5 BAEs” (B cells, IgA, Eosinophils) |
IL-6 | Can start and stop inflammation Regulates Acute Phase Reactants | — |
IL-7 | T-cell maturation | 7 looks like T |
IL-8 | Neutrophil recruitment | “Clean up on aisle 8” (Neutrophils = cleanup crew) |
IL-10 | Only anti-inflammatory Inhibits Th1, ↓ MHC II, ↓ macrophage activation | AnTEN inflammatory "IL-10 & TGF-β both shut things down" |
IL-12 | Secreted by macrophages Differentiates T cells → Th1, activates NK cells | IL12 and IFN γ → Granuloma formation in TB |
IL-13 | Promotes IgE, alternative macrophage activation, Mucus production | "thirtEEn promotes IgE" |
- Mnemonic:
- 17 → 1 → 2
- 17 → 1 → 17
- 1 → 2 → 2, γ
- 2 → 3 → 13, 4, 5
- TH17:
- Releases IL-17.
- Mnemonic: 17 year old girl dont do anything
- TH1:
- IL-2
- Interferon-gamma
- granuloma formation.
- Mnemonic: Granny (Gamma granuloma) 2 (IL2) nu poyonnu Nokkan (NK cells)
- TH2:
- IL-4
- IL-5
- IL-13
- Mnemonic: 2nd helper→ Switch (switching) idumbo → Easy (Eosinophilic) ayi → Mucus (Mucus) drain cheyyum

Cytotoxic T-cell:
- King → CD8
- CD8.
- Kill virus-infected & tumor cells
- Mechanisms:
- Apoptosis via CD95 → Extrinsic Pathway
- Perforin-Granzyme pathway.
- Express CD8, which binds MHC I on infected cells.
- Mnemonic: King is 95 year old → likes perforating grannies
CD4/CD8 Ratio:
- Normal: 2:1
- Rule of 8:
- MHC1 presents to CD8 (1x8=8, as "8 1's are 8").
- MHC2 presents to CD4 (2x4=8, as "four 2's are 8").
B Lymphocytes

B-cell Receptors:
- "Blessed with an MD degree":
- Have IgM, IgD (antibodies) as receptors from childhood.
Humoral Immunity
- Recognize & present antigen
- Undergo somatic hypermutation → improved antigen specificity
- Differentiate into plasma cells → secrete antibodies (immunoglobulins)
- Form memory B cells → faster secondary immune response
CD Markers:
Marker | Details / Function | Deficiency |
CD10 | Also known as CALLA | ㅤ |
CD20, CD21, CD22, CD23 | ㅤ | ㅤ |
→ CD19 | Pan B-cell marker | ㅤ |
→ CD21 | Receptor for Epstein Barr Virus (EBV) entry into B cells | ㅤ |
CD40 | B-cell activation / interaction with T-cells | Hyper IgM Syndrome A/w Pneumocystis Jerovicii Pneumonia |
CD79A, CD79B | Signal transduction molecules for Pan B-cell | ㅤ |
- Mnemonic: "10 → 20 → 40 → 80s double double".
- Methodology for ANA
Antibody-dependent cellular cytotoxicity (ADCC)

Types of Immunoglobulins (Ig)

General Features
- Proteins produced by plasma cells.
- Detectable > 7 days after symptoms.
- All antibodies are made of:
- 2 Heavy chains (~50,000 Da)
- 2 Light chains (~25,000 Da)
- Chains are connected by disulfide bonds
- Chains contain:
- In light chains → 1 Variable + 1 Constant region
- In heavy chains → 1 Variable + 3 or 4 Constant regions

- Fab region:
- Antigen binding site
- Antigen binds to
- hypervariable region /
CDR (Complementarity Determining Region)
- Fc region:
- Mediates biological activity (e.g., complement fixation)
Structure of Antibody
Region | Components | Function |
Fab | Variable + Constant (both chains) | Antigen binding Determines idiotype (unique antigen specificity) |
Fc | Constant (heavy chain only) | Complement binding, macrophage binding Determines isotype (IgG, IgM, etc.) Biological effects (e.g. opsonization, complement) |
Disulfide Bonds | Link heavy to heavy, heavy to light chains | Structural integrity |
Mnemonic for Fc: 5 C's
- Constant
- Carboxy terminal
- Complement binding
- Carbohydrate side chains
- Confers isotype (IgG, IgA, etc.)
Order of concentration in blood: GAMDE
- IgG > IgA > IgM > IgD > IgE


Comparison Table
- IgG crosses placenta → "G = Goes to baby"
- IgM = Massive + first Made, 5 units and 10 binding site
- IgA = Airway & secretions, A2 → 2 units
- IgE = Eosinophils, allergy, parasites
Type | Key Points | Special Features |
IgG | Highest serum concentration 1. Fixes complement (acquired immunity) 2. Crosses placenta (neonatal immunity) | 4 Subclasses: - IgG1, IgG2, IgG3, IgG4 IgG1, IgG3: Best opsonins (Garam Masala) IgG2: Does not cross placenta; Protects against capsulated organisms IgG4: Does not fix complement |
IgA Serum IgA: Monomer Secretory IgA: Dimer | Plasma (serum) or mucus (secretory) Fixes complement (alternative pathway) Present in RT, GIT, GUT, breast milk | Local mucosal immunity Secretory protein protects from enzymatic digestion |
IgM Pentamer | - Highest molecular weight - 1st antibody produced in infection - Fixes complement (classical path) - Mostly intravascular (80%) | 5 antibody units joined by J chain (Mary Jane → MJ → J units in IgM) Valency = 10 ideally, binds 5-6 antigens Key in acute inflammation |
IgD | May act as B-cell receptor Can activate alternate complement | ㅤ |
IgE | Least concentration Type I hypersensitivity, allergy Binds to mast cells, basophils | Reaginic / Homocytotropic antibody ↑ in parasitic infections |
Antibody Diversity (Antigen Independent)

- V(D)J Recombination:
- Light chain = VJ
- Heavy chain = V(D)J
- Mediated by RAG1/2

- N-nucleotide addition by TdT
- Heavy + Light chain pairing
Antibody Specificity (Antigen Dependent)
- Variable region (Ab site) → Somatic hypermutation → Affinity maturation
- Constant region → Isotype switching
- (Alternate RNA splicing)
- CD 40 - CD 40L interaction
- Process: Ig M/D → IgA/E/G

Function | Mechanism |
Neutralization | Prevents pathogen adherence to mucosal surfaces |
Opsonization | Tags pathogens for phagocytosis by macrophages |
Complement activation | Binds C1 complex → MAC formation via C3b |



Affinity Development/maturation
- Progressive increase in affinity of antibodies for antigen during immune response.
- Achieved by affinity maturation in germinal centers.
- Key steps:
- Somatic hypermutation → generates variants of BCR/antibody.
- Selection → high-affinity B cells survive, low-affinity die.
- via follicular dendritic cells + Tfh cells).
- Result:
- Secondary immune response produces high-affinity antibodies.
- Improves effectiveness of humoral immunity.
Antibody Specificity (Antigen Dependent)
- Variable region (Ab site) → Somatic hypermutation → Affinity maturation
- Constant region → Isotype switching
- (Alternate RNA splicing)
- CD 40 - CD 40L interaction
- Process: Ig M/D → IgA/E/G
Somatic Hypermutation (SHM)
- Molecular mechanism underlying affinity maturation.
- Occurs in variable (V) region of Ig genes (esp. CDRs).
- Mediated by Activation-Induced Cytidine Deaminase (AID).
- Introduces point mutations → generates B cell clones with variable affinities.
- Selection favors B cells with improved antigen binding → survive & proliferate.
B-cell and T-cell Interaction (Isotype Switching)

- Two signals are required for
- T-cell activation
- B-cell activation
- Class switching

- B cell picks up antigen → become Activated B cell → presents to T cell → B cell's CD40 receptor interact with CD40 ligand on T cell → T cell then releases IL-4
- Isotype Switching:
- Promotion of B cell from MD to GAMDE
- Requires IL4 (from T cell) and CD40
- IL-4 → B cell change from MD (IgM, IgD) to G, A, M, D, E.
- Mnemonic: "Char chalice" (IL-4 & CD40 ligand) are needed for the "change" or "switching".
Anergy
- A state where a T or B cell fails to respond to an antigen due to lack of costimulatory signal (Signal 2).
- Key in self-tolerance.
T-cell Activation

- Antigen uptake by APC → migrates to lymph node.
- Signal 1:
- Exogenous antigen → presented on MHC II → recognized by TCR on Th (CD4+) cell.
- Endogenous/cross-presented antigen → presented on MHC I → recognized by TCR on Tc (CD8+) cell.
- Signal 2:
- B7 (CD80/86) on APC binds CD28 on naïve T cell → proliferation and survival.
- Activated Th cell secretes cytokines.
- Tc cells → kill virus-infected cells.
Antigen Presenting Cells (APCs)

- Role: First cells to pick up antigen.
- Types:
- Professional APCs:
- Primary job is antigen presentation.
- Mnemonic: DBMci
- D: Dendritic cells.
- B: B cells.
- M: Macrophages.
- Non-professional APCs:
- Part-time antigen presentation.
- Epithelial cells
- Endothelial cells
- Fibroblasts.
- Mechanism:
- Present antigens on a "tray"/"plate"
- called Major Histocompatibility Complex (MHC).
Major Histocompatibility Complex (MHC)

- Control: By HLA gene on chromosome 6p.
HLA Gene Parts:
- MHC say HLo (HLA) to Antigen

- Part one
- (A, B, C)
- Makes MHC1.
- Part three
- Does NOT make MHC3.
- Makes
- complement proteins (C2, C4),
- heat shock proteins,
- TNF-alpha.
- Part two
- (DP, DQ, DR)
- Makes MHC2.
Differences between MHC1 and MHC2:

Feature | MHC1 | MHC2 |
HLA Gene Parts | A, B, C | DP, DQ, DR |
ㅤ | Binds endogenous antigens | Binds exogenous antigens |
Antigen Sits At | α1- α2 junction | α1 - β1 junction |
Mnemonic (Binding) | "MHC 1 → Only 1" | "A and B" |
Presence | All nucleated cells of body, platelets Not Present RBCs, sperms | Antigen Presenting Cells (APCs) |
Presents Antigens To (rule of 8) | CD8 T cells | CD4 T cells |
Deficiency | ㅤ | Bare Lymphocyte Syndrome |
- Mnemonic: All can present to King, but only spcl peple can present to manthri
Autoimmune Disorders and Antibodies




Disorder | Key Antibodies / Features | Mnemonic |
Scleroderma | ㅤ | ㅤ |
- Limited Scleroderma | Anti-centromere antibody. | "Limited to a place," so "centered to a place" |
- Diffuse Scleroderma | Anti-topoisomerase antibody (also Anti-SCL70). | "Diffuse" → "Topo (total body) isomease" |
SLE (Systemic Lupus Erythematosus) | Most sensitive: - Anti-nuclear antibody (ANA). Most specific: - Anti-Smith (Anti-Sm) antibody. Both sens. & spec.: - Anti-dsDNA antibody. - Mnemonic: double benifit → DNA Neonates (rona): - Anti-Ro antibody. Psychosis: - Anti-ribosomal P antibodies. | ㅤ |
Drug-induced Lupus | Caused by SHIP drugs (Sulfonamides, Hydralazine, Isoniazid, Procainamide, Dapsone). Anti-histone antibodies. | He throw stone (anti histone) if ur drug give him SLE |
Sjögren's Syndrome | Dry eyes, dry mouth. Anti-SSA (Anti-Ro), Anti-SSB (Anti-La). | Anti-SSA (Ro) "rona is sensitive"; Anti-SSB (La) "LA is specific" |
ANA Immunofluorescence Patterns:
- Mnemonic: HAPPENS
Pattern | Target Antigen | Description / Notes |
Centromere | Anti-centromere antibody | • Stains centromeres (discrete dots). • Seen in Limited Scleroderma (CREST) |
Speckled | Anti-Sm, Anti-Ro (SSA), Anti-La (SSB) | • Most common; non-specific. • Seen in SLE, Sjögren’s, Scleroderma |
Nucleolar | RNA / Nucleolar RNA | • Nucleolus stained (1–2 dots); • seen in Systemic Sclerosis |
Peripheral (Rim) | dsDNA | • Periphery of nucleus dark; • classic for SLE |
Homogeneous | Chromatin / Histone / nuclear | • Entire nucleus stained uniformly • Drug induced lupus |
Associated Disorder | Autoantibody |
Myasthenia gravis | Anti-postsynaptic ACh receptor |
Lambert-Eaton myasthenic syndrome | Anti-presynaptic voltage-gated Ca²⁺ channel |
Antiphospholipid syndrome | Anti-β₂ glycoprotein I |
Nonspecific screening antibody, often associated with SLE | Antinuclear (ANA) |
SLE, antiphospholipid syndrome | Anticardiolipin, lupus anticoagulant |
SLE | Anti-dsDNA, anti-Smith |
Drug-induced lupus | Antihistone |
Mixed connective tissue disease | Anti-UI RNP (ribonucleoprotein) |
Rheumatoid arthritis | Rheumatoid factor (IgM antibody against IgG Fc region), anti-cyclic citrullinated peptide (anti-CCP, more specific) |
Sjögren syndrome | Anti-Ro/SSA, anti-La/SSB |
Scleroderma (diffuse) | Anti-Scl-70 (anti-DNA topoisomerase I) |
Limited scleroderma (CREST syndrome) | Anticentromere |
Polymyositis, dermatomyositis | Antisynthetase (e.g., anti-Jo-1), anti-SRP, anti-helicase (anti-Mi-2) |
1° biliary cholangitis | Antimitochondrial |
Autoimmune hepatitis | Anti-smooth muscle, anti-liver/kidney microsomal-1 |
Microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis, ulcerative colitis, 1° sclerosing cholangitis | Myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)/perinuclear ANCA (p-ANCA) |
Granulomatosis with polyangiitis | PR3-ANCA/cytoplasmic ANCA (c-ANCA) |
1° membranous nephropathy | Anti-phospholipase A₂ receptor |
Bullous pemphigoid | Anti-hemidesmosome (BP 180/ 230) |
Pemphigus vulgaris | Anti-desmoglein (anti-desmosome 3 > 1) |
Hashimoto thyroiditis | Antithyroglobulin, antithyroid peroxidase (antimicrosomal) |
Graves disease | • Anti-TSH receptor, • Anti TS1 (Thyroid stimulating immunoglobulins) • Anti LATS (Long acting thyroid stimulator) |
Celiac disease | IgA anti-endomysial, IgA anti-tissue transglutaminase, IgA and IgG deamidated gliadin peptide |
Type 1 diabetes mellitus | Anti-glutamic acid decarboxylase, islet cell cytoplasmic antibodies |
Pernicious anemia | Anti-parietal cell, anti-intrinsic factor |
Goodpasture syndrome | Anti-glomerular basement membrane |
Spleen
Location & Protection
- Protected by 9th–11th ribs
Function
- Filters blood, stores WBCs and platelets
- Immune surveillance and response to blood-borne antigens
Histology Overview

Region | Contents/Function |
White pulp (WBCs) | Immune function area: lymphoid tissue |
Periarteriolar lymphatic sheath (PALS) | T cells; surrounds central arterioles |
Follicle | B cells; contains germinal center if active |
Marginal zone | Macrophages + specialized B cells; APCs capture blood-borne antigens |
Red pulp (RBCs) | Sinusoids + reticular fibers; filters old/damaged RBCs |
Circulation Types
- Open circulation: Blood passes through cords into sinusoids
- Closed circulation: Blood directly enters sinusoids
Splenic Dysfunction (e.g., post-splenectomy, sickle cell autosplenectomy)
- ↓ IgM → ↓ complement activation → ↓ C3b opsonization
- ↑ susceptibility to encapsulated organisms
Post-splenectomy Findings
- Howell-Jolly bodies (nuclear remnants)
- Target cells
- ↑↑ Platelets (↓ sequestration/removal)
- ↑↑ WBCs (↓ sequestration)
Vaccination Advice
- Vaccinate against encapsulated organisms:
- Pneumococcus
- Haemophilus influenzae type B
- Neisseria meningitidis
Thymus
- Mediastinal involvement differential diagnosis (D/D):
- T ALL
- Nodular Sclerosis → Hodgkin Lymphoma
- Thymoma
Thymus




- Site: Anterosuperior mediastinum
- Epithelium: Derived from 3rd pharyngeal pouch (endoderm)
- Lymphocytes: Derived from mesoderm
- T cells mature in Thymus
- B cells mature in Bone marrow, Spleen
Clinical Correlations
- Absent thymic shadow or hypoplastic thymus:
- Seen in SCID, DiGeorge syndrome
- Thymoma:
- Most common anterior mediastinal tumour
- Tumor of thymus
- Associated with:
- Myasthenia gravis
- Superior vena cava syndrome
- Pure red cell aplasia
- Good syndrome
General Features
- Capsulated
- "Sail-shaped" appearance on neonatal chest X-ray (CXR)
- Involutes by age 3 years
- Divided into lobules
- Each lobule has:
- Cortex:
- Darkly stained (many small lymphocytes)
- Immature T cells
- Medulla:
- Lightly stained (pale reticular cells + few lymphocytes)
- Mature T cells
- No lymphatic nodules
Lobular Structure
- Incomplete septa:
- Divide cortex, but not medulla
- Multiple cortices share common medulla
Unique Feature
- Hassalls (Thymic) corpuscles in medulla:
- Central hyaline mass
- Surrounded by concentric layers of dying reticuloepithelial cells

Differentiation of T Cells

Origin and Selection
- T-cell precursor originates in bone marrow.
- Migrates to thymus for maturation and selection.
✅ Positive Selection
- Occurs in thymic cortex.
- Selects T cells that can recognize self-MHC molecules (either class I or II).
- Only those cells get a survival signal.
❌ Negative Selection
- Eliminates T cells that bind too strongly to self-antigens.
- Occurs in thymic medulla.
Autoimmune Polyendocrine Syndrome Type 1:
- Negative selection absent
- Controlled by AIRE gene
- Drives expression of self-antigens in the thymus.
- AIRE deficiency →
- Chronic mucocutaneous candidiasis
- Hypoparathyroidism
- Adrenal insufficiency
- Recurrent Candida infections
→ Mnemonic: “Organs in air are affected → adrenal, parathyroid + candida in air will come”

IPEX Syndrome
- T Regulatory cell defect
- X linked
- Cause: FOXP3 deficiency → autoimmunity
- Immune dysregulation
- Polyendocrinopathy
- Enteropathy
- Other Symptoms:
- nail dystrophy, dermatitis
- Seen in male infants, often associated with diabetes.
Chronic Mucocutaneous Candidiasis
- Defect:
- T-cell dysfunction.
- Impaired cell-mediated immunity caused by Candida sp.
- Classic form in AIRE.
- Presentation:
- Persistent noninvasive Candida albicans infections of skin & mucous membranes.
- Findings:
- Absent in vitro T-cell proliferation in response to Candida antigens.
- Absent cutaneous reaction to Candida antigens.
IL-12 Receptor Deficiency
- Defect:
- ↓ Th1 response.
- Autosomal recessive.
- Presentation:
- Disseminated mycobacterial & fungal infections.
- May present after BCG vaccination.
- Findings:
- ↓ IFN-γ.
- Most common cause of Mendelian susceptibility to mycobacterial diseases (MSMD).